NO20081863L - Forhindring og behandling av gastrointestinal og blaerelidelse assosiert med kemoterapi eller stralingsterapi ved bruk av aktiv vitamin D forbindelse - Google Patents
Forhindring og behandling av gastrointestinal og blaerelidelse assosiert med kemoterapi eller stralingsterapi ved bruk av aktiv vitamin D forbindelseInfo
- Publication number
- NO20081863L NO20081863L NO20081863A NO20081863A NO20081863L NO 20081863 L NO20081863 L NO 20081863L NO 20081863 A NO20081863 A NO 20081863A NO 20081863 A NO20081863 A NO 20081863A NO 20081863 L NO20081863 L NO 20081863L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- active vitamin
- chemotherapy
- gastrointestinal
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Det beskrives en fremgangsmåte for prevensjon, terapi eller lindring av gastrointestinalog blæreforstyrrelser hos en pasient som mottar en kjemoterapi eller en strålingsterapi, omfattende administrering til pasienten av en terapeutisk effektiv mengde av aktiv vitamin D forbindelse eller en etterlikner derav. Det beskrives at den aktive vitamin D forbindelse eller en etterlikner derav kan administreres ved høydosepulsadministrering slik at høye doser av aktiv vitamin D forbindelse eller en etterlikner derav kan administreres til et dyr uten å indusere alvorlig, symptomatisk hyperkalcemi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71998805P | 2005-09-26 | 2005-09-26 | |
PCT/US2006/037246 WO2007038428A2 (en) | 2005-09-26 | 2006-09-26 | Prevention and treatment of gastrointestinal and bladder disorders using active vitamin d compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081863L true NO20081863L (no) | 2008-06-04 |
Family
ID=37900359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081863A NO20081863L (no) | 2005-09-26 | 2008-04-17 | Forhindring og behandling av gastrointestinal og blaerelidelse assosiert med kemoterapi eller stralingsterapi ved bruk av aktiv vitamin D forbindelse |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090163453A1 (no) |
EP (1) | EP1928471A2 (no) |
JP (1) | JP2009513567A (no) |
KR (1) | KR20080063790A (no) |
AU (1) | AU2006294819A1 (no) |
BR (1) | BRPI0616330A2 (no) |
CA (1) | CA2622470A1 (no) |
IL (1) | IL190067A0 (no) |
NO (1) | NO20081863L (no) |
WO (1) | WO2007038428A2 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002363959B2 (en) * | 2001-12-03 | 2007-12-13 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US8501717B2 (en) * | 2007-02-09 | 2013-08-06 | Merck, Sharp & Dohme Corp. | Methods to treat and/or prevent mucositis |
EP1972341A1 (en) * | 2007-03-23 | 2008-09-24 | Novartis AG | Pharmaceutical compositions comprising a bisphosphonate and vitamin D |
GB0813628D0 (en) * | 2008-07-25 | 2008-09-03 | Arrow Int Ltd | Stable coated anti-cancer agent |
PL388252A1 (pl) * | 2009-06-10 | 2010-12-20 | Instytut Farmaceutyczny | Terapia skojarzona raka jelita grubego |
IT1396937B1 (it) * | 2009-11-26 | 2012-12-20 | Bruzzese | Formulazioni di bisfosfonati e vitamina d idonee alla somministrazione intermittente per via intramuscolare e sottocutanea |
JP5686841B2 (ja) * | 2013-04-26 | 2015-03-18 | フレゼニウス メディカル ケア ドイッチェランド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 損傷しまたは傷害を受けた組織または臓器の内皮/上皮再生用医薬の製造のための、幹細胞由来微小胞(mv)の使用ならびにインビトロおよびインビボでの関連した方法 |
CA2930817A1 (en) | 2013-11-17 | 2015-05-21 | Rdd Pharma Ltd. | Methods for treating radiation induced gastrointestinal tract injury |
CN104758300A (zh) * | 2014-01-02 | 2015-07-08 | 上海泽生科技开发有限公司 | 维生素d及其组合物的抗菌用途 |
EP3053598A1 (en) | 2015-02-06 | 2016-08-10 | Faes Farma, S.A. | Calcifediol soft capsules |
KR102381242B1 (ko) | 2016-01-13 | 2022-03-31 | 엘지전자 주식회사 | 냉장고 |
WO2018215936A1 (en) | 2017-05-24 | 2018-11-29 | Novartis Ag | Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer |
CN111450104A (zh) * | 2020-05-22 | 2020-07-28 | 中国人民解放军第二军医大学 | 维生素d在防治辐射所致肠损伤中的用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6204615B1 (en) * | 1997-02-21 | 2001-03-20 | Intelilite, L.L.C. | Intelligent outdoor lighting control system |
US6891838B1 (en) * | 1998-06-22 | 2005-05-10 | Statsignal Ipc, Llc | System and method for monitoring and controlling residential devices |
US6989377B2 (en) * | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
WO2003024391A2 (en) * | 2001-08-16 | 2003-03-27 | Mucosal Therapeutics, Inc. | Treatment and prevention of mucositis in cancer patients |
US20050101576A1 (en) * | 2003-11-06 | 2005-05-12 | Novacea, Inc. | Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes |
AU2003295773A1 (en) * | 2002-11-21 | 2004-06-18 | Novacea, Inc. | Treatment of liver disease with active vitamin d compounds |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
JP2007501865A (ja) * | 2003-06-11 | 2007-02-01 | ノバセア インコーポレイティッド | 放射線治療薬および放射線治療と併用した、活性ビタミンd化合物による癌の治療法 |
JP2007502867A (ja) * | 2003-06-11 | 2007-02-15 | ノバセア インコーポレイティッド | 他の治療法と併用した、活性ビタミンd化合物による肺癌の治療法 |
EP1631297A4 (en) * | 2003-06-11 | 2007-09-05 | Novacea Inc | TREATMENT OF IMMUNOSTIC DISEASES WITH ACTIVE VITAMIN D COMPOUNDS ALONE OR IN COMBINATION WITH OTHER THERAPEUTICS |
EP1750728A4 (en) * | 2004-05-10 | 2009-04-29 | Novacea Inc | PREVENTION AGAINST ARTERIAL RESTENOSIS USING ACTIVE VITAMIN D COMPOUNDS |
WO2005117542A2 (en) * | 2004-05-10 | 2005-12-15 | Novacea, Inc. | Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments |
BRPI0606393A2 (pt) * | 2005-01-05 | 2009-06-23 | Novacea Inc | prevenção de doenças trombóticas com compostos ativos de vitamina d ou similares do mesmo |
US20080069814A1 (en) * | 2005-01-05 | 2008-03-20 | Novacea, Inc. | Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof |
-
2006
- 2006-09-26 CA CA002622470A patent/CA2622470A1/en not_active Abandoned
- 2006-09-26 KR KR1020087010087A patent/KR20080063790A/ko not_active Application Discontinuation
- 2006-09-26 WO PCT/US2006/037246 patent/WO2007038428A2/en active Application Filing
- 2006-09-26 BR BRPI0616330-0A patent/BRPI0616330A2/pt not_active Application Discontinuation
- 2006-09-26 US US11/992,300 patent/US20090163453A1/en not_active Abandoned
- 2006-09-26 JP JP2008532473A patent/JP2009513567A/ja active Pending
- 2006-09-26 EP EP06815330A patent/EP1928471A2/en not_active Withdrawn
- 2006-09-26 AU AU2006294819A patent/AU2006294819A1/en not_active Abandoned
-
2008
- 2008-03-11 IL IL190067A patent/IL190067A0/en unknown
- 2008-04-17 NO NO20081863A patent/NO20081863L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007038428A2 (en) | 2007-04-05 |
KR20080063790A (ko) | 2008-07-07 |
BRPI0616330A2 (pt) | 2011-06-14 |
US20090163453A1 (en) | 2009-06-25 |
JP2009513567A (ja) | 2009-04-02 |
IL190067A0 (en) | 2008-12-29 |
CA2622470A1 (en) | 2007-04-05 |
AU2006294819A1 (en) | 2007-04-05 |
EP1928471A2 (en) | 2008-06-11 |
WO2007038428A3 (en) | 2009-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081863L (no) | Forhindring og behandling av gastrointestinal og blaerelidelse assosiert med kemoterapi eller stralingsterapi ved bruk av aktiv vitamin D forbindelse | |
JP2015519329A5 (no) | ||
PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
NO20070702L (no) | Kombinasjonsbehandling for ikke-hematologisk malignitet ved anvendelse av anti-OGF-1R antistoff | |
MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
NO20070597L (no) | Medikamtenter for a behandle kronisk respiratorisk sykdom. | |
AR090885A1 (es) | Uso de laquinimod en alta dosis para el tratamiento de la esclerosis multiple | |
JP2017510607A5 (no) | ||
MX2020010034A (es) | Metodo de tratamiento de enfermedad fibrotica. | |
MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
GT200600263A (es) | Regimen de dosificacion para prasugrel | |
NO20075393L (no) | Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse | |
WO2007079195A3 (en) | Gastric retentive gabapentin dosage forms and methods for using same | |
NO20075945L (no) | Behandling, prevensjon og ameliorasjon av lungelidelser assosiert med kjemoterapi eller radioterapi med aktive vitamin D sammensetninger eller imitatorer derav | |
JP2016505050A5 (no) | ||
WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
MX2017005163A (es) | Composiciones de liberación prolongada de onapristona y métodos. | |
JP2019529569A5 (no) | ||
WO2017142871A8 (en) | Methods comprising fixed intermittent dosing of cediranib | |
IL310909A (en) | Dosing regimens associated with delayed-release injectable formulations of paliperidone | |
MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. | |
MX2021007324A (es) | Terapia oral con acido 6,8-bis-benciltio-octanoico. | |
AR109760A1 (es) | Composiciones y métodos para tratar el mal de alzheimer y la enfermedad de parkinson | |
BRPI0509305A (pt) | uso de um sensibilizador insulìnico, composição farmecêutica, e , kit | |
FI4065134T3 (fi) | Rautasuksinaatin antaminen suun kautta käytettäväksi raudanpuutoksen hoidossa potilailla, joilla on sydämen vajaatoiminta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |